Transcend Medical closes $22mln Series C
Transcend Medical, a medical device company dedicated to the development of minimally invasive glaucoma interventions for the ophthalmic surgeon, has closed a $22 million Series C preferred equity investment. Existing investors and an undisclosed global pharmaceutical and medical device company participated in the round.
2 April 2014•3 mins read
